Antibiotic overproduction by rpsL and rsmG mutants of various actinomycetes

Area of Science:

• Microbiology
• Molecular Biology
• Genetics

Background:

• Streptomycin resistance mutations are linked to altered antibiotic biosynthesis in actinomycetes.
• Specific mutations, rpsL and rsmG, are known to influence secondary metabolite production.
• The interplay between resistance mechanisms and antibiotic overproduction requires further investigation.

Purpose of the Study:

• To investigate the impact of streptomycin resistance mutations (rpsL and rsmG) on antibiotic production in actinomycetes.
• To determine if combined rpsL and rsmG mutations lead to enhanced antibiotic yields.
• To explore the effect of these mutations on the transcription of developmental regulator genes.

Main Methods:

• Generating and characterizing single (rpsL, rsmG) and double (rpsL rsmG) mutant strains of actinomycetes.
• Quantifying antibiotic production levels in wild-type versus mutant strains.
• Analyzing the transcriptional changes of key genes, such as bldD, using molecular techniques.

Main Results:

• Single rpsL and rsmG mutations in various actinomycetes resulted in the overproduction of antibiotics.
• rpsL and rsmG double-mutant strains exhibited a further increase in antibiotic production compared to single mutants.
• rpsL mutations specifically enhanced oligomycin production in Streptomyces avermitilis and erythromycin production in Saccharopolyspora erythraea.
• Enhanced antibiotic production in Saccharopolyspora erythraea correlated with increased transcription of the bldD gene.

Conclusions:

• Streptomycin resistance mutations, particularly rpsL, are potent drivers of antibiotic overproduction in actinomycetes.
• The combination of rpsL and rsmG mutations synergistically enhances antibiotic yields.
• The rpsL mutation's effect on antibiotic production is linked to the regulation of developmental genes like bldD.